November 2, 2022 —  A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly elevated risk for myocarditis or pericarditis after mRNA 

November 2, 2022 —  Researchers have developed a three-dimensional model that shows how exposure to cadmium might lead to congenital heart disease. Affecting nearly 40,000 newborns a year, congenital heart disease is the most common type of birth defect in the United States. The model was created by scientists at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health.

November 2, 2022 — The second round of late-breaking clinical trial results were announced at VIVA22 on Nov. 1 in Las Vegas, NV.

November 2, 2022 — A number of awards of distinction were presented during The VEINS (Venous Endovascular INterventional Strategies) 2022 Conference Oct. 30-31, in Las Vegas, NV.

November 1, 2022 — Deepak L. Bhatt, MD, MPH, a top expert in cardiovascular medicine and interventional cardiology, has been named Director of Mount Sinai Heart. Dr. Bhatt will lead the educational, research, and clinical cardiovascular work of the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System beginning Thursday, December 1. He will also serve as the Dr.

November 1, 2022 — Cleerly, the company creating a new standard of care for heart disease, announced a new workflow solution to its portfolio, Proxy. 

Johnson & Johnson to Acquire Abiomed

November 1, 2022 — Johnson & Johnson and Abiomed, a world leader in breakthrough heart, lung and kidney support technologies, today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire through a tender offer all outstand
DAIC's Top 10 for the month of October

Here is what you and your colleagues found to be most interesting in the fields of diagnostic and interventional cardiology during the month of October.

1. AHA Scientific Sessions 2022 Program, Late-breakers Announced

2. Image Gallery Showing Impact of the COVID-19 Pandemic

October 31, 2022 — Results from the Late-Breaking Clinical Trials session at The VEINS Conference in Las Vegas, NV, were announced on Oct.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now